Shan Wang

Background

About Shan Wang

In June 2022, I joined Clarivate after graduate study at University of Pennsylvania. At Clarivate, I am involved in the US market access team and responsible for conducting market analysis for pharmaceutical and biotechnology companies. I have contributed to several projects that involved researching, analyzing, and presenting market data and trends for various therapeutic areas and products, such as asthma, oncology, CAR-Ts, precision medicine and rare diseases like ALS. I have collaborated with global team members, clients, payers, and healthcare profession stakeholders to deliver high-quality and timely results, influencing their strategic decisions and outcomes. I have also leveraged my previous experiences as an R&D intern at Sanofi and a consultant at Penn Biotech Group, where I gained valuable insights into the clinical and scientific aspects of the biopharma industry. I am motivated by the opportunity to learn from and contribute to a diverse and dynamic team, and to make a positive impact on the healthcare sector.